Real-time Stock quotes, portfolio, LIVE TV and more.
1.95 (0.35%)
3.35 (0.6%) 2.01 pm | 05 Dec 2006
Broking house, Edelweiss Research is bullish on Nicholas Piramal and has recommended buy rating on the stock....
11.08 am | 01 Dec 2006
Rajesh Jain of Pranav Securities is of the view that one should accumulate pharma stocks on decline. ...
8.08 am | 21 Nov 2006
Nicholas Piramal India Ltd has entered into a scientific collaboration agreement with BioSyntech Inc around a drug being developed to alleviate heel p...
1.33 pm | 23 Oct 2006
Broking house, India Infoline is bullish on Nicholas Piramal. It has maintained buy rating on the stock with a target price of Rs 277....
12.00 pm | 19 Oct 2006
Broking house, P-Sec has recommended accumulate Nicholas Piramal on decline....
4.19 pm | 18 Oct 2006
Chairman at Nicholas Piramal, Ajay Piramal says that in the whole custom manufacturing business, they have got about Rs 450 crore of revenues. ...
2.51 pm | 18 Oct 2006
Nicholas Piramal has announced its second quarter consolidated results. The company's net profit was up at Rs 53.6 crore from Rs 45.6 crore. ...
7.51 pm | 17 Oct 2006
Nicholas Piramal's Q2 numbers are to come out. CNBC-TV18's research analyst Sunita Nagpal previews them. ...
9.02 am | 16 Oct 2006
Nicholas Piramal India Limited (NPIL) came into existence in 1988 when the company Nicholas Laboratories was acquired from Aspro Nicholas by the Mumba...
3.35 pm | 12 Oct 2006
As the India UK Investment Summit comes to a close, one definite conclusion that can be drawn from it is that business leaders from India and the UK f...
3.11 pm | 11 Oct 2006
Broking house, DSP Merrill Lynch expects that Nicholas Piramal is to post net profit of Rs 62.3 crore and net sales of Rs 616 crore in the quarter end...
3.42 pm | 07 Oct 2006
Broking house, Angel Broking expects that Nicholas is to post net sales of Rs 445 crore and net profit of Rs 45 crore in Q2FY07. It has recommended bu...
9.11 am | 04 Oct 2006
Drug-maker Nicholas Piramal India Ltd (NPIL) has acquired the balance 51 per cent equity held by The Boots Company Plc in joint venture company Boots ...
1.29 pm | 19 Sep 2006
Shahina Mukadam of IDBI Capital Markets says that acquisitions done by pharma companies will start delivering from next year. According to Prashant Va...
9.38 am | 19 Sep 2006
Broking house, P-sec is bullish on Nicholas Piramal and has maintained buy rating with a price target of Rs 268....
9.30 am | 19 Sep 2006
Standard and Poors has selected seven Indian companies as a part of a global emerging challengers list. This means that it expects these companies to ...
6.16 pm | 18 Sep 2006
Seven Indian companies expected to emerge as Challengers to the World's leading Blue Chips, S&P says ...
10.57 am | 14 Sep 2006
Ajay Piramal, Chairman of Nicholas Piramal says that their growth model is to look at custom manufacturing as well as research. These are their future...
6.43 pm | 04 Sep 2006
Nicholas Piramal’s Wellspring acquires 100 pc stake in Dr Phadke’s path labs...
7.17 pm | 20 Jul 2006
Nicholas Piramal came out with its numbers today. Ajay Piramal, Chairman of Nicholas Piramal attributes the slipping of margins to increase in R&D exp...